Table 2 Comparison between Phase II and Phase I rapid ES in the NICU.
From: Integrating rapid exome sequencing into NICU clinical care after a pilot research study
[days; median (IQR) unless otherwise noted] | Phase II n = 80a | Phase I n = 35 | p valueb |
---|---|---|---|
Diagnostic Yield (number (%)) | 22 (28%) | 20 (57%) | 0.003 |
Age at genetics consult | 10.5 (4, 52) | 7 (3, 26.5) | 0.236 |
Interval from NICU admission to genetics consultc | 2 (1, 4) | 1 (1, 2) | 0.114 |
Interval from genetics consult to sample collection | 4 (2, 15.8) | 3 (1, 7) | 0.119 |
Interval from sample collection to ES reportd | 13 (10, 16.8) | 13 (10, 14) | 0.333 |
Interval from genetics consult to ES report | 18 (15, 35) | 16 (14, 19.5) | 0.019 |
Interval from NICU admission to ES report | 20 (16, 29) | 17 (15, 19) | 0.016 |
Age at ES report | 45.5 (22, 98) | 28 (18.5, 53) | 0.015 |